Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2004 Sep;74(1):1-7.
doi: 10.1002/jmv.20138.

Persistent infection of SARS coronavirus in colonic cells in vitro

Paul K S Chan  1 , Ka-Fai To, Anthony W I Lo, Jo L K Cheung, Ida Chu, Florence W L Au, Joanna H M Tong, John S Tam, Joseph J Y Sung, Ho-Keung Ng
Affiliations

Persistent infection of SARS coronavirus in colonic cells in vitro

Paul K S Chan et al. J Med Virol. 2004 Sep.

Abstract

Severe acute respiratory syndrome coronavirus (SARS-CoV) can produce gastrointestinal symptoms. The intestinal tract is the only extrapulmonary site where viable viruses have been detected. This study examined seven established human intestinal cell lines, DLD-1, HCT-116, HT-29, LoVo, LS-180, SW-480 and SW-620, for their permissiveness to SARS-CoV infection. The results showed that only LoVo cells were permissive to SARS-CoV infection as evident by positive findings from indirect immunofluorescence staining for intracellular viral antigens, in situ hybridization for intracellular viral RNA, and electron microscopy for intracellular viral particles. In contrast to Vero cells, SARS-CoV did not produce cytopathic effects on LoVo cells. However, LoVo cells were found to be highly permissive for productive infection with a high viral titre (>3 x 10(7) viral copies/ml) produced in culture supernatant following a few days of incubation. SARS-CoV established a stable persistent chronic infection that could be maintained after multiple passages. Being a cell line of human origin, LoVo cells could be a useful in vitro model for studying the biology and persistent infection of SARS-CoV. Our results on the expression of angiotensin-converting enzyme 2 (ACE2), a recently identified cellular receptor for SARS-CoV, in these cell lines indicated that it might not be the sole determinant for cells to be susceptible to SARS-CoV infection.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Chan PKS, Tam JS, Lam CW, Chan E, Wu A, Li CK, Buckley TA, Ng KC, Joynt GM, Cheng FWT, To KF, Lee N, Hui DS, Cheung JL, Chu I, Liu E, Chung SS, Sung JJY. 2003. Human metapneumovirus detection in patients with severe acute respiratory syndrome. Emerg Infect Dis 9: 1058–1063. - PMC - PubMed
    1. Chan PKS, Ng KC, Chan RCW, Lam RKY, Chow VCY, Hui M, Wu A, Lee N, Yap HY, Cheng FWT, Sung JJY, Tam JS. 2004a. Immunofluorescence assay for serologic diagnosis of SARS. Emerg Infect Dis 10: 530–532. - PMC - PubMed
    1. Chan PKS, To WK, Ng KC, Lam RKY, Ng TK, Chan RCW, Wu A, Yu WC, Lee N, Hui DSC, Lai ST, Hon EKL, Li CK, Sung JJY, Tam JS. 2004b. Laboratory Diagnosis of SARS. Emerg Infect Dis 10: 825–831. - PMC - PubMed
    1. Drosten C, Gunther S, Preiser W, van der WS, Brodt HR, Becker S, Rabenau H, Panning M, Kolesnikova L, Fouchier RA, Berger A, Burguiere AM, Cinatl J, Eickmann M, Escriou N, Grywna K, Kramme S, Manuguerra JC, Muller S, Rickerts V, Sturmer M, Vieth S, Klenk HD, Osterhaus AD, Schmitz H, Doerr HW. 2003. Identification of a novel coronavirus in patients with severe acute respiratory syndrome. N Engl J Med 348: 1967–1976. - PubMed
    1. Fouchier RA, Kuiken T, Schutten M, van Amerongen G, van Doornum GJ, van den Hoogen BG, Peiris M, Lim W, Stohr K, Osterhaus AD. 2003. Aetiology: Koch's postulates fulfilled for SARS virus. Nature 423: 240. - PMC - PubMed

Publication types

MeSH terms

LinkOut - more resources